Beta-Cell Specific Deletion of Dicer1 Leads to Defective Insulin Secretion and Diabetes Mellitus

Mature microRNAs (miRNAs), derived through cleavage of pre-miRNAs by the Dicer1 enzyme, regulate protein expression in many cell-types including cells in the pancreatic islets of Langerhans. To investigate the importance of miRNAs in mouse insulin secreting β-cells, we have generated mice with a β-cells specific disruption of the Dicer1 gene using the Cre-lox system controlled by the rat insulin promoter (RIP). In contrast to their normoglycaemic control littermates (RIP-Cre+/− Dicer1 Δ/wt), RIP-Cre+/− Dicer1flox/flox mice (RIP-Cre Dicer1 Δ/Δ) developed progressive hyperglycaemia and full-blown diabetes mellitus in adulthood that recapitulated the natural history of the spontaneous disease in mice. Reduced insulin gene expression and concomitant reduced insulin secretion preceded the hyperglycaemic state and diabetes development. Immunohistochemical, flow cytometric and ultrastructural analyses revealed altered islet morphology, marked decreased β-cell mass, reduced numbers of granules within the β-cells and reduced granule docking in adult RIP-Cre Dicer1 Δ/Δ mice. β-cell specific Dicer1 deletion did not appear to disrupt fetal and neonatal β-cell development as 2-week old RIP-Cre Dicer1 Δ/Δ mice showed ultrastructurally normal β-cells and intact insulin secretion. In conclusion, we have demonstrated that a β-cell specific disruption of the miRNAs network, although allowing for apparently normal β-cell development, leads to progressive impairment of insulin secretion, glucose homeostasis and diabetes development.

[1]  L. Eliasson,et al.  Differential Glucose-Regulation of MicroRNAs in Pancreatic Islets of Non-Obese Type 2 Diabetes Model Goto-Kakizaki Rat , 2011, PloS one.

[2]  Y. Dor,et al.  miRNAs control insulin content in pancreatic β‐cells via downregulation of transcriptional repressors , 2011, The EMBO journal.

[3]  L. Eliasson,et al.  Differences in islet-enriched miRNAs in healthy and glucose intolerant human subjects. , 2011, Biochemical and biophysical research communications.

[4]  Xiaoxiao Hu,et al.  Brain expression of Cre recombinase driven by pancreas‐specific promoters , 2010, Genesis.

[5]  David W. Taylor,et al.  A Novel miRNA Processing Pathway Independent of Dicer Requires Argonaute2 Catalytic Activity , 2010, Science.

[6]  G. Hannon,et al.  A dicer-independent miRNA biogenesis pathway that requires Ago catalysis , 2010, Nature.

[7]  James Sharpe,et al.  Quantification and Three-Dimensional Imaging of the Insulitis-Induced Destruction of β-Cells in Murine Type 1 Diabetes , 2010, Diabetes.

[8]  M. Gorospe,et al.  Minireview: posttranscriptional regulation of the insulin and insulin-like growth factor systems. , 2010, Endocrinology.

[9]  R. Regazzi,et al.  Role and therapeutic potential of microRNAs in diabetes , 2009, Diabetes, obesity & metabolism.

[10]  Mihaela Zavolan,et al.  miR-375 maintains normal pancreatic α- and β-cell mass , 2009, Proceedings of the National Academy of Sciences.

[11]  T. Ochiya,et al.  Dicer Is Required for Maintaining Adult Pancreas , 2009, PloS one.

[12]  L. Eliasson,et al.  Insulin secretion is highly sensitive to desorption of plasma membrane cholesterol , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  Nathan L. Vanderford,et al.  Glucose regulation of insulin gene expression in pancreatic beta-cells. , 2008, The Biochemical journal.

[14]  N. Baroukh,et al.  miR-375 Targets 3′-Phosphoinositide–Dependent Protein Kinase-1 and Regulates Glucose-Induced Biological Responses in Pancreatic β-Cells , 2008, Diabetes.

[15]  D. R. Laybutt,et al.  Alterations in MicroRNA Expression Contribute to Fatty Acid–Induced Pancreatic β-Cell Dysfunction , 2008, Diabetes.

[16]  L. O’Driscoll,et al.  Molecular medicine of microRNAs: structure, function and implications for diabetes , 2008, Expert Reviews in Molecular Medicine.

[17]  Lena Eliasson,et al.  Novel aspects of the molecular mechanisms controlling insulin secretion , 2008, The Journal of physiology.

[18]  R. Regazzi,et al.  Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs , 2008, Biological chemistry.

[19]  C. Ricordi,et al.  Quantitative differential expression analysis reveals miR-7 as major islet microRNA. , 2008, Biochemical and biophysical research communications.

[20]  Michael T. McManus,et al.  MicroRNA Expression Is Required for Pancreatic Islet Cell Genesis in the Mouse , 2007, Diabetes.

[21]  B. Wajchenberg.  beta-cell failure in diabetes and preservation by clinical treatment. , 2007, Endocrine reviews.

[22]  Zlatko Trajanoski,et al.  CARMAweb: comprehensive R- and bioconductor-based web service for microarray data analysis , 2006, Nucleic Acids Res..

[23]  R. Ketting.  Partners in dicing , 2006, Genome Biology.

[24]  George A. Calin,et al.  Mammalian microRNAs: a small world for fine-tuning gene expression , 2006, Mammalian Genome.

[25]  Matthias Merkenschlager,et al.  T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer , 2005, The Journal of experimental medicine.

[26]  George E. Sandusky,et al.  Dicer Is Required for Embryonic Angiogenesis during Mouse Development* , 2005, Journal of Biological Chemistry.

[27]  Shridar Ganesan,et al.  Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. , 2005, Genes & development.

[28]  N. Rajewsky,et al.  A pancreatic islet-specific microRNA regulates insulin secretion , 2004, Nature.

[29]  S. Elledge,et al.  Dicer is essential for mouse development , 2003, Nature Genetics.

[30]  Lena Eliasson,et al.  Fast insulin secretion reflects exocytosis of docked granules in mouse pancreatic B-cells , 2002, Pflügers Archiv.

[31]  F. Pattou,et al.  Identification and Purification of Functional Human β-cells by a New Specific Zinc-fluorescent Probe , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[32]  L. Groop.  Pathogenesis of type 2 diabetes: the relative contribution of insulin resistance and impaired insulin secretion. , 2000, International journal of clinical practice. Supplement.

[33]  J. Hutton,et al.  Translational regulation of proinsulin biosynthesis and proinsulin conversion in the pancreatic beta-cell. , 2000, Seminars in cell & developmental biology.

[34]  P. Herrera,et al.  Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. , 2000, Development.

[35]  M. Magnuson,et al.  Analysis of the Cre‐mediated recombination driven by rat insulin promoter in embryonic and adult mouse pancreas , 2000, Genesis.

[36]  M. Noda,et al.  Identification of the docked granule pool responsible for the first phase of glucose-stimulated insulin secretion. , 1999, Diabetes.

[37]  H. Edlund,et al.  Insulin-promoter-factor 1 is required for pancreas development in mice , 1994, Nature.

[38]  W. Rutter,et al.  Onset of cell-specific gene expression in the developing mouse pancreas. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[39]  N. Baroukh,et al.  miR-375 targets PDK 1 and regulates glucose-induced biological responses in pancreatic β-cells , 2008 .

[40]  James Sharpe,et al.  Tomographic molecular imaging and 3D quantification within adult mouse organs , 2007, Nature Methods.

[41]  S. Efendić,et al.  Dysfunction of the islet lysosomal system conveys impairment of glucose-induced insulin release in the diabetic GK rat. , 1999, Endocrinology.